Lynparza bags EU approval for RCA-mutated advanced ovarian cancer

19th June 2019 Uncategorised 0

The approval was based on data from the pivotal Phase III SOLO-1 trial.

More: Lynparza bags EU approval for RCA-mutated advanced ovarian cancer
Source: News